# Crescent Capital BDC, Inc.: overview CCAP · Nasdaq · CIK 1633336 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ccap.md) · [Financials](/companies/ccap/financials.md) · [Filings](/companies/ccap/filings.md) · [Insiders](/companies/ccap/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.64](/filings/0001193125-25-277533.md) | not reported | [0.45](/filings/0001193125-26-221936.md) | [0.46](/filings/0000950170-25-108024.md) | [0.46](/filings/0001193125-25-277533.md) | not reported | [0.42](/filings/0001193125-26-221936.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.67](/filings/0000950170-24-017903.md) | [1.93](/filings/0000950170-25-023153.md) | [2.30](/filings/0001193125-26-071922.md) | [2.40](/filings/0001193125-26-071922.md) | [1.81](/filings/0001193125-26-071922.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ccap/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Texas County & District Retirement System](/funds/1698632.md) | 2026-06-30 | $54.6m | 5,001,752 | | Unchanged | | [Fidelity National Financial, Inc.](/funds/1331875.md) | 2026-06-30 | $45.9m | 4,205,307 | | Unchanged | | [Blackstone Inc.](/funds/1393818.md) | 2026-06-30 | $45.9m | 4,205,306 | | Reduced −1 | | [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $11.9m | 1,088,183 | | Added +541,774 | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $10.9m | 1,000,313 | | Reduced −28,653 | | [RIVERNORTH CAPITAL MANAGEMENT, LLC](/funds/1447578.md) | 2026-06-30 | $7.7m | 702,796 | | New +702,796 | | [North Ground Capital](/funds/2055446.md) | 2026-06-30 | $5.7m | 520,800 | | Added +181,893 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5.5m | 501,743 | | Added +146,135 | | [Mariner, LLC](/funds/1373442.md) | 2026-06-30 | $4.8m | 441,119 | | Reduced −22,246 | | [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $4.8m | 437,177 | | Reduced −19,778 | ## Recent filings [All 526 filings](/companies/ccap/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-10 | 20:15 ET | [8-K](/filings/0001193125-26-342415.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342415 | | 2026-08-10 | 20:07 ET | [10-Q](/filings/0001193125-26-342351.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342351 | | 2026-07-01 | 20:05 ET | [8-K](/filings/0001193125-26-292528.md) | 8.01 Other events | 0001193125-26-292528 | | 2026-06-24 | 20:08 ET | [8-K](/filings/0001193125-26-281053.md) | 2.03 New direct financial obligation | 0001193125-26-281053 | | 2026-05-27 | 20:07 ET | [8-K](/filings/0001193125-26-241887.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-241887 | | 2026-05-18 | 21:12 ET | [8-K](/filings/0001193125-26-229127.md) | 5.07 Shareholder vote results | 0001193125-26-229127 | | 2026-05-13 | 21:24 ET | [8-K](/filings/0001193125-26-221986.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221986 | | 2026-05-13 | 21:12 ET | [10-Q](/filings/0001193125-26-221936.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221936 | | 2026-05-08 | 20:05 ET | [8-K](/filings/0001193125-26-214602.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-214602 | | 2026-04-01 | 20:15 ET | [DEF 14A](/filings/0001140361-26-012755.md) | Proxy statement, period 2026-05-15 | 0001140361-26-012755 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-071922.md), filed Feb 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1633336 - Tickers: CCAP - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.